Servín-González Luis Steven, Granados-López Angelica Judith, López Jesús Adrián
Laboratorio de microRNAs, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, Av. Preparatoria S/N, Zacatecas 98066, Mexico.
Doctorado en Ciencias Básicas, Universidad Autónoma de Zacatecas, Av. Preparatoria S/N, Campus II, Zacatecas 98066, Mexico.
Int J Mol Sci. 2015 Jun 5;16(6):12773-90. doi: 10.3390/ijms160612773.
Tumor cells have developed advantages to acquire hallmarks of cancer like apoptosis resistance, increased proliferation, migration, and invasion through cell signaling pathway misregulation. The sequential activation of genes in a pathway is regulated by miRNAs. Loss or gain of miRNA expression could activate or repress a particular cell axis. It is well known that aberrant miRNA expression is well recognized as an important step in the development of cancer. Individual miRNA expression is reported without considering that miRNAs are grouped in clusters and may have similar functions, such as the case of clusters with anti-oncomiRs (23b27b24-1, miR-29a29b-1, miR-29b-229c, miR-99a125b-2, miR-99b125a, miR-100125b-1, miR-199a-2214, and miR-302s) or oncomiRs activity (miR-1-1133a-2, miR-1-2133a-1, miR-133b206, miR-1792, miR-106a363, miR18396182, miR-181a-1181b-1, and miR-181a-2~181b-2), which regulated mitogen-activated protein kinases (MAPK), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), NOTCH, proteasome-culling rings, and apoptosis cell signaling. In this work we point out the pathways regulated by families of miRNAs grouped in 20 clusters involved in cervical cancer. Reviewing how miRNA families expressed in cluster-regulated cell path signaling will increase the knowledge of cervical cancer progression, providing important information for therapeutic, diagnostic, and prognostic methodology design.
肿瘤细胞通过细胞信号通路失调获得了诸如抗凋亡、增殖增加、迁移和侵袭等癌症特征优势。通路中基因的顺序激活受微小RNA(miRNA)调控。miRNA表达的缺失或增加可激活或抑制特定细胞轴。众所周知,异常的miRNA表达是癌症发展的重要步骤。以往报道单个miRNA的表达时,未考虑到miRNA是成簇存在且可能具有相似功能,例如具有抗肿瘤miRNA(23b27b24-1、miR-29a29b-1、miR-29b-229c、miR-99a125b-2、miR-99b125a、miR-100125b-1、miR-199a-2214和miR-302s)或致癌miRNA活性(miR-1-1133a-2、miR-1-2133a-1、miR-133b206、miR-1792、miR-106a363、miR18396182、miR-181a-1181b-1和miR-181a-2~181b-2)的簇,这些簇调控丝裂原活化蛋白激酶(MAPK)、磷脂酰肌醇-4,5-二磷酸3-激酶(PI3K)、NOTCH、蛋白酶体-剔除环和凋亡细胞信号。在这项工作中,我们指出了参与宫颈癌的20个簇中miRNA家族所调控的通路。回顾簇调控的细胞信号通路中miRNA家族的表达情况,将增加对宫颈癌进展的认识,为治疗、诊断和预后方法设计提供重要信息。